Progression or Regression of Barrett's Esophagus - Is it All in the Eye of the Beholder?

American Journal of Gastroenterology

Volumn 98, Issue 12, 2003, Pages 2612-2615

  Dekel, Roy ^a   Wakelin, Donald E ^a   Wendel, Chris ^a   Green, Colleen ^a   Sampliner, Richard E ^a   Garewal, Harinder S ^a   Martinez, Patricia ^a   Fass, Ronnie ^a,b  

^a UNIVERSITY OF ARIZONA   (United States)

^b SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; BARRETT ESOPHAGUS LENGTH; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE COURSE; ESOPHAGUS; ESOPHAGUS MUCOSA; FEMALE; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; HUMAN; INTESTINE BIOPSY; INTESTINE METAPLASIA; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OBSERVER VARIATION; PRIORITY JOURNAL; RELIABILITY; REMISSION;

EID: 0347364711     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(03)00665-8     Document Type: Article

References (15)

1. Sampliner RE, The Practice Parameters Committee of the American College of Gastroenterology. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 2002;97:1888-95.
2. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265:1287-9.
3. Devesa SS, Blot WJ, Fraumeni JF, Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;83:2049-53.
4. Spechler SJ, Goyal RK. Barrett's esophagus. N Engl J Med 1986;3185:362-71.
5. Fass R, Sampliner RE. Gastroesophageal reflux disease and Barrett's esophagus. In: DiMarino AJ Jr, Benjamin SB, eds. Gastrointestinal disease, an endoscopic approach. 2nd ed. Thorofare, NJ: Slack, 2002:191-214.
6. Padda S, Ramirez FC. Accuracy in the diagnosis of short-segment Barrett's esophagus: The role of endoscopic experience. Gastrointest Endosc 2001;54:605-8.
7. Cameron AJ, Lomboy CT. Barrett's esophagus: Age, prevalence, and extent of columnar epithelium. Gastroenterology 1992;103:1241-5.
8. Neumann CS, Iqbal TH, Cooper BT. Long term continuous omeprazole treatment of patients with Barrett's oesophagus. Aliment Pharmacol Ther 1995;9:451-4.
9. Sharma P, Sampliner RE, Camargo E. Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus. Am J Gastroenterol 1997;92:582-5.
10. Malesci A, Savarino V, Zentilin P, et al. Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole. Gastrointest Endosc 1996;44:700-5.
11. Wilkinson SP, Biddlestone L, Gore S, Shepherd NA. Regression of columnar-lined (Barrett's) oesophagus with omeprazole 40 mg daily: Results of 5 years of continuous therapy. Aliment Pharmacol Ther 1999;13:1205-9.
12. Gore S, Healey CJ, Sutton R, et al. Regression of columnar lined (Barrett's) oesophagus with continuous omeprazole therapy. Aliment Pharmacol Ther 1993;7:623-8.
13. Peters FT, Ganesh S, Kuipers EJ, et al. Endoscopic regression of Barrett's oesophagus during omeprazole treatment: A randomised double blind study. Gut 2000;45:489-94.
14. Srinivasan R, Katz PO, Ramakrishnan A, et al. Maximal acid reflux control for Barrett's oesophagus: Feasible and effective. Aliment Pharmacol Ther 2001;15:519-24.
15. Sampliner RE, Fennerty B, Garewal HS. Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: Preliminary results. Gastrointest Endosc 1996;44:532-5.